Join us on LinkedIn for the latest news.

Upwards arrow: Go back to top
We use cookies to improve the user experience.
You can read more about our Cookie Policy here.
Accept

Latest & Greatest

Get to know the whole team, stay up to date and find out what drives us as successful life science enthusiasts and company builders.

follow us on linkedin
A man standing on the stage of the Annual Network Event in front of an audience.
?

News & Press

Learn more about recent advances in biotech, health tech and our work.

See all press releases
Auron Announces First Patient Dosed in Phase 1 Clinical Trial of AUTX-703 in Advanced Hematologic MalignanciesAuron Announces First Patient Dosed in Phase 1 Clinical Trial of AUTX-703 in Advanced Hematologic MalignanciesAuron Announces First Patient Dosed in Phase 1 Clinical Trial of AUTX-703 in Advanced Hematologic Malignancies
29.5.25
Auron Announces First Patient Dosed in Phase 1 Clinical Trial of AUTX-703 in Advanced Hematologic Malignancies
Learn more
Download PDF
Learn more
Therini Bio Raises Additional $39M Series A Financing to Advance Clinical Development of Neurodegenerative Disease PipelineTherini Bio Raises Additional $39M Series A Financing to Advance Clinical Development of Neurodegenerative Disease PipelineTherini Bio Raises Additional $39M Series A Financing to Advance Clinical Development of Neurodegenerative Disease Pipeline
14.5.25
Therini Bio Raises Additional $39M Series A Financing to Advance Clinical Development of Neurodegenerative Disease Pipeline
Learn more
Download PDF
Learn more

Our Blog

Where we share what we are passionate about: insights from Apollo Health Ventures